| 产品详情 |
| Edit |   |
|---|
| Product Name | Influenza A, Netherlands 219/03 (H7N7), Hemagglutinin, Recombinant |
|---|
| Description | Purity ≥ 90% as determined by: (a) Analysis by RP-HPLC. (b) Anion-exchange FPLC. (c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel. Recombinant HA- H7N7 Netherlands 219/03 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 57,500 dalton. Dimers and Aggregates: Less than 1% as determined by silver-stained SDS-PAGE gel analysis. Endotoxin: ≤ 0.1ng/ug (IEU/ug) of Recombinant HA. Stability: rHA although stable at 15°C for 2 weeks, should be stored at 4°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please do not freeze. |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | I7649-96 |
|---|
| Price | |
|---|
| Order / More Info | Influenza A, Netherlands 219/03 (H7N7), Hemagglutinin, Recombinant from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|